ID   PIGW_HUMAN              Reviewed;         504 AA.
AC   Q7Z7B1; Q8N9G3;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   10-MAY-2017, entry version 102.
DE   RecName: Full=Phosphatidylinositol-glycan biosynthesis class W protein {ECO:0000305};
DE            Short=PIG-W {ECO:0000303|PubMed:14517336};
DE            EC=2.3.-.- {ECO:0000250|UniProtKB:Q7TSN4};
GN   Name=PIGW {ECO:0000312|HGNC:HGNC:23213};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=14517336; DOI=10.1091/mbc.E03-03-0193;
RA   Murakami Y., Siripanyapinyo U., Hong Y., Kang J.Y., Ishihara S.,
RA   Nakakuma H., Maeda Y., Kinoshita T.;
RT   "PIG-W is critical for inositol acylation but not for flipping of
RT   glycosylphosphatidylinositol-anchor.";
RL   Mol. Biol. Cell 14:4285-4295(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-416, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [4]
RP   INVOLVEMENT IN HPMRS5, VARIANTS HPMRS5 PRO-71 AND VAL-167,
RP   CHARACTERIZATION OF VARIANTS HPMRS5 PRO-71 AND VAL-167, AND FUNCTION.
RX   PubMed=24367057; DOI=10.1136/jmedgenet-2013-102156;
RA   Chiyonobu T., Inoue N., Morimoto M., Kinoshita T., Murakami Y.;
RT   "Glycosylphosphatidylinositol (GPI) anchor deficiency caused by
RT   mutations in PIGW is associated with West syndrome and
RT   hyperphosphatasia with mental retardation syndrome.";
RL   J. Med. Genet. 51:203-207(2014).
CC   -!- FUNCTION: Required for the transport of GPI-anchored proteins to
CC       the plasma membrane (PubMed:24367057). Probable acetyltransferase,
CC       which acetylates the inositol ring of phosphatidylinositol during
CC       biosynthesis of GPI-anchor. Acetylation during GPI-anchor
CC       biosynthesis is not essential for the subsequent mannosylation and
CC       is usually removed soon after the attachment of GPIs to proteins
CC       (By similarity). {ECO:0000250|UniProtKB:Q7TSN4,
CC       ECO:0000269|PubMed:24367057}.
CC   -!- PATHWAY: Glycolipid biosynthesis; glycosylphosphatidylinositol-
CC       anchor biosynthesis. {ECO:0000250|UniProtKB:Q7TSN4}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q7TSN4}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q7TSN4}.
CC   -!- DISEASE: Hyperphosphatasia with mental retardation syndrome 5
CC       (HPMRS5) [MIM:616025]: An autosomal recessive neurologic disorder
CC       characterized by developmental delay, mental retardation, tonic
CC       seizures associated with hypsarrhythmia, dysmorphic facial
CC       features, and elevated serum alkaline phosphatase.
CC       {ECO:0000269|PubMed:24367057}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the PIGW family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB097818; BAC77021.1; -; mRNA.
DR   EMBL; AK094752; BAC04413.1; -; mRNA.
DR   CCDS; CCDS11313.1; -.
DR   RefSeq; NP_001333683.1; NM_001346754.1.
DR   RefSeq; NP_001333684.1; NM_001346755.1.
DR   RefSeq; NP_848612.2; NM_178517.4.
DR   UniGene; Hs.378885; -.
DR   ProteinModelPortal; Q7Z7B1; -.
DR   BioGrid; 129756; 8.
DR   STRING; 9606.ENSP00000332313; -.
DR   iPTMnet; Q7Z7B1; -.
DR   PhosphoSitePlus; Q7Z7B1; -.
DR   BioMuta; PIGW; -.
DR   DMDM; 74713752; -.
DR   MaxQB; Q7Z7B1; -.
DR   PaxDb; Q7Z7B1; -.
DR   PeptideAtlas; Q7Z7B1; -.
DR   PRIDE; Q7Z7B1; -.
DR   DNASU; 284098; -.
DR   Ensembl; ENST00000614443; ENSP00000482202; ENSG00000277161.
DR   Ensembl; ENST00000616581; ENSP00000481144; ENSG00000275600.
DR   Ensembl; ENST00000620233; ENSP00000480021; ENSG00000277161.
DR   Ensembl; ENST00000631508; ENSP00000488033; ENSG00000275600.
DR   GeneID; 284098; -.
DR   KEGG; hsa:284098; -.
DR   UCSC; uc002hmz.2; human.
DR   CTD; 284098; -.
DR   DisGeNET; 284098; -.
DR   GeneCards; PIGW; -.
DR   H-InvDB; HIX0019575; -.
DR   HGNC; HGNC:23213; PIGW.
DR   HPA; HPA023499; -.
DR   MalaCards; PIGW; -.
DR   MIM; 610275; gene.
DR   MIM; 616025; phenotype.
DR   neXtProt; NX_Q7Z7B1; -.
DR   OpenTargets; ENSG00000277161; -.
DR   Orphanet; 247262; Hyperphosphatasia-intellectual disability syndrome.
DR   PharmGKB; PA134894412; -.
DR   eggNOG; KOG0411; Eukaryota.
DR   eggNOG; COG5062; LUCA.
DR   GeneTree; ENSGT00390000013520; -.
DR   HOGENOM; HOG000204712; -.
DR   HOVERGEN; HBG079452; -.
DR   InParanoid; Q7Z7B1; -.
DR   KO; K05283; -.
DR   OMA; THWNFFF; -.
DR   OrthoDB; EOG091G07LB; -.
DR   PhylomeDB; Q7Z7B1; -.
DR   Reactome; R-HSA-162710; Synthesis of glycosylphosphatidylinositol (GPI).
DR   UniPathway; UPA00196; -.
DR   ChiTaRS; PIGW; human.
DR   GenomeRNAi; 284098; -.
DR   PRO; PR:Q7Z7B1; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000184886; -.
DR   CleanEx; HS_PIGW; -.
DR   ExpressionAtlas; Q7Z7B1; baseline and differential.
DR   Genevisible; Q7Z7B1; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0008374; F:O-acyltransferase activity; TAS:Reactome.
DR   GO; GO:0006505; P:GPI anchor metabolic process; IC:UniProtKB.
DR   GO; GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IMP:UniProtKB.
DR   InterPro; IPR009447; GWT1.
DR   PANTHER; PTHR20661; PTHR20661; 1.
DR   Pfam; PF06423; GWT1; 1.
DR   PIRSF; PIRSF017321; GWT1; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Glycoprotein; GPI-anchor biosynthesis;
KW   Membrane; Mental retardation; Phosphoprotein; Reference proteome;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    504       Phosphatidylinositol-glycan biosynthesis
FT                                class W protein.
FT                                /FTId=PRO_0000246282.
FT   TOPO_DOM      1     21       Lumenal. {ECO:0000255}.
FT   TRANSMEM     22     42       Helical. {ECO:0000255}.
FT   TRANSMEM     74     94       Helical. {ECO:0000255}.
FT   TRANSMEM    132    152       Helical. {ECO:0000255}.
FT   TRANSMEM    163    183       Helical. {ECO:0000255}.
FT   TRANSMEM    203    223       Helical. {ECO:0000255}.
FT   TRANSMEM    238    258       Helical. {ECO:0000255}.
FT   TRANSMEM    261    281       Helical. {ECO:0000255}.
FT   TRANSMEM    306    326       Helical. {ECO:0000255}.
FT   TRANSMEM    339    359       Helical. {ECO:0000255}.
FT   TRANSMEM    371    391       Helical. {ECO:0000255}.
FT   TRANSMEM    449    469       Helical. {ECO:0000255}.
FT   TRANSMEM    474    494       Helical. {ECO:0000255}.
FT   MOD_RES     416    416       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CARBOHYD     15     15       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      71     71       T -> P (in HPMRS5; compound heterozygote
FT                                with V-167; reduced protein abundance;
FT                                decreased function in GPI-anchored
FT                                protein transport; dbSNP:rs587777733).
FT                                {ECO:0000269|PubMed:24367057}.
FT                                /FTId=VAR_071933.
FT   VARIANT     167    167       M -> V (in HPMRS5; compound heterozygote
FT                                with P-71; no effect on protein
FT                                abundance; loss of function in GPI-
FT                                anchored protein transport;
FT                                dbSNP:rs200024253).
FT                                {ECO:0000269|PubMed:24367057}.
FT                                /FTId=VAR_071934.
FT   CONFLICT    126    126       N -> D (in Ref. 2; BAC04413).
FT                                {ECO:0000305}.
SQ   SEQUENCE   504 AA;  56882 MW;  6CACD6EFD154DDE2 CRC64;
     MSEKQMKEAF VSNLNGTTVL EITQGLCFPA FCILCRGFLI IFSQYLCSFS PTWKTRFLTD
     FVVLIVPMVA TLTIWASFIL LELLGVIIFG AGLLYQIYRR RTCYARLPFL KILEKFLNIS
     LESEYNPAIS CFRVITSAFT AIAILAVDFP LFPRRFAKTE LYGTGAMDFG VGGFVFGSAM
     VCLEVRRRKY MEGSKLHYFT NSLYSVWPLV FLGIGRLAII KSIGYQEHLT EYGVHWNFFF
     TIIVVKLITP LLLIIFPLNK SWIIALGITV LYQLALDFTS LKRLILYGTD GSGTRVGLLN
     ANREGIISTL GYVAIHMAGV QTGLYMHKNR SHIKDLIKVA CFLLLAAISL FISLYVVQVN
     VEAVSRRMAN LAFCIWIVAS SLILLSSLLL GDIILSFAKF LIKGALVPCS WKLIQSPVTN
     KKHSESLVPE AERMEPSLCL ITALNRKQLI FFLLSNITTG LINLMVDTLH SSTLWALFVV
     NLYMFSNCLI VYVLYLQDKT VQFW
//
